A
Andrea Gallina
Researcher at Vita-Salute San Raffaele University
Publications - 384
Citations - 12166
Andrea Gallina is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Prostatectomy & Prostate cancer. The author has an hindex of 57, co-authored 346 publications receiving 10573 citations. Previous affiliations of Andrea Gallina include University of Pavia & Université de Montréal.
Papers
More filters
Journal ArticleDOI
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
Alberto Briganti,Alessandro Larcher,Firas Abdollah,Umberto Capitanio,Andrea Gallina,Nazareno Suardi,Marco Bianchi,Maxine Sun,Massimo Freschi,Andrea Salonia,Pierre I. Karakiewicz,Patrizio Rigatti,Francesco Montorsi +12 more
TL;DR: The first update of a nomogram predicting the presence of LNI in patients treated with ePLND is reported, which maintained high accuracy, even in more contemporary patients (87.6%) and should be mandatory in any LNI prediction model.
Journal ArticleDOI
Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study
Andrea Necchi,Andrea Anichini,Daniele Raggi,Alberto Briganti,Simona Massa,Roberta Lucianò,Maurizio Colecchia,Patrizia Giannatempo,Roberta Mortarini,Marco Bianchi,Elena Farè,Francesco Monopoli,Renzo Colombo,Andrea Gallina,Andrea Salonia,Antonella Messina,Siraj M. Ali,Russell Madison,Jeffrey S. Ross,Jon Chung,Roberto Salvioni,Luigi Mariani,Francesco Montorsi +22 more
TL;DR: It is indicated that pembrolizumab could be a worthwhile neoadjuvant therapy for the treatment of MIBC when limited to patients with PD-L1-positive or high-TMB tumors.
Journal ArticleDOI
Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate Cancer
Alberto Briganti,Felix K.-H. Chun,Andrea Salonia,Nazareno Suardi,Andrea Gallina,Luigi F. Da Pozzo,Marco Roscigno,Giuseppe Zanni,Luc Valiquette,Patrizio Rigatti,Francesco Montorsi,Pierre I. Karakiewicz +11 more
TL;DR: The data indicate that, even in the hands of experienced urologic surgeons, ePLNDs are associated with higher complication rates and longer hospital stay and these detriments need to be taken into account when the staging benefit associated with ePL ND is considered.
Journal ArticleDOI
Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy
Alberto Briganti,Jeffrey Karnes,Luigi F. Da Pozzo,Cesare Cozzarini,Andrea Gallina,Nazareno Suardi,Marco Bianchi,Massimo Freschi,Claudio Doglioni,Ferruccio Fazio,Patrizio Rigatti,Francesco Montorsi,Michael L. Blute +12 more
TL;DR: In this paper, the authors proposed to stratify node positive patients according to the number of positive nodes to improve cancer specific survival (CSS) prediction, and showed that patients with up to 2 positive nodes experienced a significantly higher overall survival compared to patients with more than 2 nodes.
Journal ArticleDOI
Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.
Nazareno Suardi,Giorgio Gandaglia,Andrea Gallina,Ettore Di Trapani,Vincenzo Scattoni,D. Vizziello,Vito Cucchiara,Roberto Bertini,Renzo Colombo,Maria Picchio,Giampiero Giovacchini,Francesco Montorsi,Alberto Briganti +12 more
TL;DR: Salvage LND may represent a therapeutic option for patients with BCR after RP and nodal pathologic uptake at 11C-choline PET/CT scan and the presence of retroperitoneal lymph node metastases were significantly associated with the risk of CR.